CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome

Ann‐Christin Pecher(Center for Rheumatology), Claudia Lengerke(STZ eyetrial), Christian Seitz(German Cancer Research Center), Reinhild Klein(University Children's Hospital Tübingen), Luca Hensen(University Children's Hospital Tübingen), Janine Schneider(University Children's Hospital Tübingen), Daniel Atar(University Children's Hospital Tübingen), Anna Stanger(University Children's Hospital Tübingen), Marina Schmidt(University Children's Hospital Tübingen), Rebekka Schairer(University Children's Hospital Tübingen), Christiane Braun(University Children's Hospital Tübingen), Marius Horger(University of Tübingen), Christoph Faul(University Children's Hospital Tübingen), K. Lutz(University Children's Hospital Tübingen), Jörg Henes(University of Tübingen), Antje Bornemann(University Children's Hospital Tübingen), Wolfgang Bethge(University of Tübingen)
JAMA
June 27, 2023
10.1001/jama.2023.8753
Cited by 234

Related Papers

Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
|Human Molecular Genetics|2005|566
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
|Blood|2010|430
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
|JAMA|2011|320
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)
|Journal of Clinical Oncology|2017|248
Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation
|Journal of Clinical Oncology|2013|212